PUMA BIOTECHNOLOGY, INC. (PBYI) Operating income 2016–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual operating income history from SEC filings — each fiscal year as reported.
$37.3MFY2025 · since FY2016: -$276.6M → $37.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.3M | +20.5% |
| FY2024 | $31.0M | -5.1% |
| FY2023 | $32.6M | +37.6% |
| FY2022 | $23.7M | +1738.8% |
| FY2021 | $1.3M | +104.2% |
| FY2020 | -$30.4M | +22.1% |
| FY2019 | -$39.0M | +58.8% |
| FY2018 | -$94.7M | +67.6% |
| FY2017 | -$292.4M | -5.7% |
| FY2016 | -$276.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice